Compare AbCellera Biologics Inc (ABCL) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Matson Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Matson Inc trades at $204.7 (market cap $6.11B). The key difference: Matson Inc is far larger — about 2× AbCellera Biologics Inc's market cap, and Matson Inc pays a 0.74% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MATX | |
|---|---|---|
Market Cap | $2.99B | $6.11B |
Sector | Health | Technology |
52-Week High | $9.76 | $223.55 |
52-Week Low | $2.78 | $88.05 |
Enterprise Value | $2.58B | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
